Action to Control Cardiovascular Risk in Diabetes Study Group, H. C. Gerstein, M. E. Miller, R. P. Byington, D. C. Goff, Jr., J. T. Bigger, J. B. Buse, W. C. Cushman, S. Genuth, F. Ismail-Beigi, R. H. Grimm, Jr., J. L. Probstfield, D. G. Simons-Morton, and W. T. Friedewald. 2008. Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 358(24):2545–2559.
Berk, R. A., and P. H. Rossi. 1999. Thinking about program evaluation 2. Thousand Oaks, CA: Sage Publications, Inc.
BetterEvaluation. 2014. BetterEvaluation: Sharing information to improve evaluation. http://betterevaluation.org (accessed April 7, 2014).
Carugi, C. 2014. Panel 4: Analyzing data using triangulation in a mixed methods evaluation to reach overall findings, conclusions, and recommendations. Paper presented at the Board on Global Health Workshop, Evaluation Methods for Large-Scale, Complex, Multi-National Global Health Initiatives, London, United Kingdom, Wellcome Trust, April 17.
Goodman, C. 2014. Panel 2: Developing the evaluation design and methodological approaches. Paper presented at the Board on Global Health Workshop, Evaluation Methods for Large-Scale, Complex, Multi-National Global Health Initiatives, London, United Kingdom, Wellcome Trust, April 17.
IOM (Institute of Medicine). 2013. Evaluation of PEPFAR. Washington, DC: The National Academies Press.
IOM and NRC (National Research Council). 2010. Strategic approach to the evaluation of programs implemented under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Washington, DC: The National Academies Press.
Lauer, M. S., and R. B. D’Agostino. 2013. The randomized registry trial—the next disruptive technology in clinical research? New England Journal of Medicine 369(17):1579–1581.
Leeuw, F., and J. Vaessen. 2009. Impact evaluations and development: NONIE guidance on impact evaluation. Washington, DC: Network of Networks on Impact Evaluation (NONIE).
Patton, M. P. 2002. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage Publications, Inc.
Pawson, R. 2013. The science of evaluation: A realist manifesto. London: Sage.
Rogers, P. J. 2008. Using programme theory to evaluate complicated and complex aspects of interventions. Evaluation 14(1):29–48.
Rossi, P. H., M. W. Lipsey, and H. E. Freeman. 2004. Evaluation: A systematic approach. Thousand Oaks, CA: Sage Publications, Inc.
Royse, D., B. A. Thyer, and D. K. Padgett. 2009. Program evaluation: An introduction. 5th ed. Belmont, CA: Wadsworth, Cengage Learning.
Sherry, J., S. Mookherji, and L. Ryan. 2009. The five-year evaluation of the Global Fund to fight AIDS, TB and malaria: Synthesis of study areas 1, 2 and 3. Calverton, MD: Macro International, Inc.
Simon, J., K. Yeboah-Antwi, A. Schapira, M. K. Cham, R. Barber-Madden, and M. I. Brooks. 2011. External evaluation of the president’s malaria initiative: Final report executive summary. Washington, DC: The Global Health Technical Assistance Project.
Stern, E., N. Stame, J. Mayne, K. Forss, R. Davies, and B. Befani. 2012. Broadening the range of designs and methods for impact evaluations: Report of a study commissioned by the Department for International Development. (working paper 38). United Kingdom: Department for International Development.
Tougher, S., Y. Ye, J. H. Amuasi, I. A. Kourgueni, R. Thomson, C. Goodman, A. G. Mann, R. Ren, B. A. Willey, C. A. Adegoke, A. Amin, D. Ansong, K. Bruxvoort, D. A. Diallo, G. Diap, C. Festo, B. Johanes, E. Juma, A. Kalolella, O. Malam, B. Mberu, S. Ndiaye, S. B. Nguah, M. Seydou, M. Taylor, S. T. Rueda, M. Wamukoya, F. Arnold, and K. Hanson. 2012. Effect of the affordable medicines facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: A before-and-after analysis of outlet survey data. Lancet 380(9857):1916–1926.
Verguet, S., R. Laxminarayan, and D. T. Jamison. 2014. Universal public finance of tuberculosis treatment in india: An extended cost-effectiveness analysis. Health Economics.
Vickerman, P., C. Watts, S. Delany, M. Alary, H. Rees, and L. Heise. 2006. The importance of context: Model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sexually Transmitted Diseases 33(6):397–405.
White, H., and D. Phillips. 2012. Addressing attribution of cause and effect in small n impact evaluations: Towards an integrated framework (working paper 15). New Delhi, India: International Initiative for Impact Evaluation (3ie).
WHO (World Health Organization). 2000. The world health report 2000. Health systems: Improving performance. Geneva, Switzerland: World Health Organization.